Advertisement

Liver Cancer pp 241-248 | Cite as

Detection of Combined Hepatocellular and Cholangiocarcinomas: Enhanced Computed Tomography

  • Akihiro Nishie
  • Kengo Yoshimitsu
Chapter
  • 1.6k Downloads
Part of the Methods of Cancer Diagnosis, Therapy and Prognosis book series (HAYAT, volume 5)

Most primary liver cancers are grossly divided into two histologic categories: hepatocellular carcinoma (HCC), derived from hepatocytes, and cholangiocellular carcinoma (CC), arising from the intra-hepatic bile duct epithelium. Combined hepatocellular and cholangiocarcinoma (cHCC-CC) is a rare form of primary liver cancer presenting histologic evidence of both hepatocellular and biliary epithelial differentiation, and is seen in 1.0–3.3% of surgically treated patients with pri mary liver tumors (The liver cancer study group of Japan, 1990; Aoki et al., 1993). Comparing the clinicopathological fea tures of patients with cHCC-CC with those of HCC or CC patients has yielded somewhat conflicting results in several studies. In many studies, cHCC-CC was found to be more prevalent in males (Lee et al., 2002). The incidence of positive hepatitis B or C serological test results in the cHCC-CC group is reported to be intermediate between that in the HCC group and in the CC group (Liu et al., 2003; Koh et al., 2005), or to be similar to that in the HCC group (Yano et al., 2003). Furthermore, the incidence of underlying chronic liver disease in the cHCC-CC group is also intermediate between that in the HCC group and in the CC group (Yano et al., 2003; Liu et al., 2003), or similar to that in the HCC group (The liver cancer study group of Japan, 1990). On the other hand, Jarnagin et al. (2001) reported that the incidence of positive hepatitis B or C serology and liver cirrhosis in patients with cHCC-CC was similar to that in CC patients. The reasons for the difference in this clinicopathological feature may include the difference between Western and Asian societies in the cause of liver cancer or the difference in the selection criteria of patients for hepatic resection (Liu et al., 2003). The survival rate in patients with cHCC-CC has been reported to be worse than that in patients with HCC or CC (Jarnagin et al., 2001; Yano et al., 2003; Liu et al., 2003), while Koh et al. (2005) concluded that the cHCC-CC group had a prognosis that was better than the CC group but worse than the HCC group. We have not come to a conclusion about clinicopathological features of cHCC-CC at the present time, and more cases must be analyzed to elucidate them.

In our daily practice we tend to be distressed at the difficulty of making a preoperative diagnosis of this type of tumor because it is rarely encountered. In an examination performed by The liver cancer study group of Japan (1990), the frequency of lymph node metastases in patients with cHCC-CC was 76.2% and was as high as that in patients with CC, while that in patients with HCC is 30.3%. Some of the literature suggests that there was a need for a lymph node resection dur ing a hepatectomy for cHCC-CC (Uenishi et al., 2000; Sasaki et al., 2001; Eguchi et al., 2002). Therefore, it is important to make a diagnosis of cHCC-CC preopera-tively.

Keywords

Compute Tomography Finding Fine Needle Aspiration Biopsy Primary Liver Cancer Intermediate Cell Bile Duct Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen, R. A., and Lisa, J. R. 1949. Combined liver cell and bile duct carcinoma. Am. J. Pathol. 25:647–655.PubMedGoogle Scholar
  2. Aoki, K., Takayasu, K., Kawano, T., Muramatsu, Y., Moriyama, N., Wakao, F., Yamamoto, J., Shimada, K., Takayama, T., Kosuge, T., Yamasaki, S., Sakamoto, M., and Hirohashi, S. 1993. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 18:1090–1095.PubMedCrossRefGoogle Scholar
  3. Choi, B. I., Han, J. K., Kim, Y. I., Kim, H. C., Park, J. H., Kim, C. W., and Han, M. C. 1994. Combined hepatocellular and cholangiocarci-noma of the liver: sonography, CT, angiography, and iodized-oil CT with pathologic correlation. Abdom. Imaging 19:43–46.PubMedCrossRefGoogle Scholar
  4. Dusenbery, D. 1997. Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases. Acta Cytol. 41:903–909.PubMedGoogle Scholar
  5. Eguchi, H., Nagano, H., Sakon, M., Miyamoto, A., Kondo, M., Arai, I., Morimoto, O., Dono, K., Umeshima, K., Nakamori, S., Wasaka, K., and Monden, M. 2002. A successful resection and long-term survival of a patient with intrahepatic recurrences of combined hepatocellular-cholan-giocarcinoma: report of a case. Surg. Today 32:742–746.PubMedCrossRefGoogle Scholar
  6. Fujita, M., Kuroda, C., Inoue, E., Kumatani, T., Hosomi, N., Narumi, Y., Kuriyama, K., Kadota, T., Kasugai, H., Sasaki, Y., and Ishiguro, S. 1996. Usefulness of spiral CT in the detection of hypovascular, well-differentiated hepatocel-lular carcinoma [in Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 56:155–159.PubMedGoogle Scholar
  7. Fukukura, Y., Taguchi, J., Nakashima, O., Wada, Y., and Kojiro, M. 1997. Combined hepatocellu-lar and cholangiocarcinoma: correlation between CT findings and clinicopathological features. J. Comput. Assist. Tomogr. 21:52–58.PubMedCrossRefGoogle Scholar
  8. Gibson, J. 1978. Histological typing of tumors of the liver, biliary tract, and pancreas. Geneva, Switzerland: World Health Organization.Google Scholar
  9. Goodman, Z. D., Ishak, K. D., Langloss, J. M., Sesterhenn, I. A., and Rabin, L. 1985. Combined hepatocellular-cholangiocarcinoma. A histo-logic and immunohistochemical study. Cancer 55:124–135.PubMedCrossRefGoogle Scholar
  10. Honda, H., Ochiai, K., Adachi, E., Yasumori, K., Hayashi, T., Kawashima, A., Fukuya, T., Gibo, M., Matsumata T., Tsuneyoshi M., and Masuda, K. 1993a. Hepatocellular carcinoma: correlation of CT, angiographic, and histopathologic findings. Radiology 189:857–862.Google Scholar
  11. Honda, H., Onitsuka, H., Adachi, E., Ochiai, K., Gibo, M., Yasumori, K., Matsumata, T. Sugimachi, K., and Masuda, K. 1993b. Intrahepatic peripheral cholangiocarcinoma: two-phased dynamic incremental CT and patho logic correlation. J. Comput. Assist. Tomogr. 17:397–402.CrossRefGoogle Scholar
  12. Itai, Y., Ohtomo, K., Kokubo, T., Yamaushi, T., Minami, M., Yashiro, N., and Araki, T. 1986. CT of hepatic masses: significance of prolonged and delayed enhancement. Am. J. Roentgenol. 146:729–733.Google Scholar
  13. Jarnagin, W. R., Weber, S., Tickoo, S. K., Koea, J. B., Obiekwe, S., Fong, Y., DeMatteo, R. P., Blumgart, L. H., and Klimstra, D. 2001. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 94:2040–2046.CrossRefGoogle Scholar
  14. Kim, H., Park, C., Han, K., Choi, J., Kim, Y. B., Kim, J. K., and Park, Y. N. 2004. Primary liver carcinoma of intermediate (hepatocyte-cholangi-ocyte) phenotype. J. Hepatol. 40:298–304.PubMedCrossRefGoogle Scholar
  15. Koh, K. C., Lee, H., Choi, M. S., Lee, J. H., Paik, S. W., Yoo, B. C., Rhee, J. C., Cho, J. W., Park, C. K., and Kim, H. J. 2005. Clinicopathological features and prognosis of combined hepatocellular cholangiocarcinoma. Am. J. Surg. 189:120–125.PubMedCrossRefGoogle Scholar
  16. Lee, C. C., Wu, C. Y., Chen, J. T., and Chen, G. H. 2002. Comparing combined hepatoc-cellular-cholangiocarcinoma and cholan-giocarcinoma: a clinicopathological study. Hepatogastroenterology 49:1487–1490.PubMedGoogle Scholar
  17. Liu, C. L., Fan, S., Lo, C., Ng, I. O., Lam, C., Poon, R. T., and Wong J. 2003. Hepatic resection for combined hepatocellular and cholangiocarci-noma. Arch. Surg. 138:86–90.PubMedCrossRefGoogle Scholar
  18. Muramatsu, Y., Takayasu, K., Moriyama, N., Shima, Y., Goto, H., Ushio, K., Yamada T., Hasegawa, H., Koyama, Y., and Hirohashi, S. 1986. Peripheral low-density area of hepatic tumors: CT-pathologic correlation. Radiology 160:49–52.PubMedGoogle Scholar
  19. Nishie, A., Yoshimitsu, K., Asayama, Y., Irie, H., Aibe, H., Tajima, T., Shinozaki, K., Nakayama, T., Kakihara, D., Shimada, M., Aishima, S., Yoshida, K., and Honda, H. 2005. Detection of combined hepatocellular and cholangiocarcino-mas on enhanced CT: comparison with histologic findings. Am. J. Roentgenol. 184:1157–1162.Google Scholar
  20. Sasaki, A., Kawano, K., Aramaki, M., Ohno, T., Tahara, K., Takeuchi, Y., Yoshida, T., and Kitano, S. 2001. Clinicopathological study of mixed hepatocellular and cholangiocellular carcinoma: modes of spreading and choice of surgical treat ment by reference to macroscopic type. J. Surg. Oncol. 76:37–46.PubMedCrossRefGoogle Scholar
  21. Taguchi, J., Nakashima, O., Tanaka, M., Hisaka, T., Takazawa, T., and Kojiro, M. 1996. A clinico-pathological study on combined hepatocellu-lar and cholangiocarcinoma. J. Gastroenterol. Hepatol. 11:758–764.PubMedCrossRefGoogle Scholar
  22. The liver cancer study group of Japan. 1990. Primary liver cancer in Japan: clinicopatho-logical features and results of surgical treatment. Ann. Surg. 221:277–287.Google Scholar
  23. Uenishi, T., Hirohashi, K., Shuto, T., Yamamoto, T., Kubo, S., Tanaka, H., Ikebe, T., and Kinoshita, H. 2000. Surgery for mixed hepa-tocellular and cholangiocellular carcinoma. Hepatogastroenterology 47:832–834.PubMedGoogle Scholar
  24. Wee, A., and Nilsson, B. 1999. Combined hepa-tocellular-cholangiocarcinoma: diagnostic chal lenge in hepatic fine needle aspiration biopsy. Acta Cytol. 43:131–138.PubMedGoogle Scholar
  25. Yamashita, Y., Fan, Z. M., Yamamoto, H., Matsukawa, T., Arakawa, A., Miyazaki, T., Harada, M., and Takahashi, M. 1993. Sclerosing hepatocellular carcinoma: radiologic findings. Abdom. Imaging 18:347–351.PubMedCrossRefGoogle Scholar
  26. Yano, Y., Yamamoto, J., Kosuge T., Sakamoto, Y., Yamasaki, S., Shimada, K., Ojima, H., Sakamoto, M., Takayama, T., and Makuuchi, M. 2003. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn. J. Clin. Oncol 33:283–287.PubMedCrossRefGoogle Scholar
  27. Yoshida, Y., Imai, Y., Murakami, T., Nishikawa, M., Kurokawa, M., Yonezawa, T., Tokunaga, K., Fukushima, Y., Wakasa, K., Kim, T., Nakamura, H., Sakon, M., and Monden, M. 1999. Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom. Imaging 24:66–68.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media B.V. 2009

Authors and Affiliations

  • Akihiro Nishie
    • 1
  • Kengo Yoshimitsu
    • 1
  1. 1.Department of Clinical RadiologyGraduate School of Medical Sciences, Kyushu UniversityMaidashi, Higashi-kuJapan

Personalised recommendations